Report overview
Cancer genome sequencing refers to a method used to identify the complete DNA or RNA sequence of cancer cells based on the sequencing of a single, homogeneous or heterogeneous group of tumor cells.
This report contains market size and forecasts of Cancer Genome Sequencing in Global, including the following market information:
Global Cancer Genome Sequencing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cancer Genome Sequencing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Second Generation Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cancer Genome Sequencing include Agilent Technologies, GE Healthcare Life Sciences, Johnson & Johnson, LI-COR Biosciences, Abbott Laboratories, Beckman Coulter, Bayer, Hamilton Thorne Biosciences and Integrated DNA Technologies, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Genome Sequencing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Genome Sequencing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cancer Genome Sequencing Market Segment Percentages, by Type, 2021 (%)
Second Generation
Third Generation
Global Cancer Genome Sequencing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cancer Genome Sequencing Market Segment Percentages, by Application, 2021 (%)
Treatment
Research
Global Cancer Genome Sequencing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cancer Genome Sequencing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Genome Sequencing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cancer Genome Sequencing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Agilent Technologies
GE Healthcare Life Sciences
Johnson & Johnson
LI-COR Biosciences
Abbott Laboratories
Beckman Coulter
Bayer
Hamilton Thorne Biosciences
Integrated DNA Technologies
Microchip Biotechnologies
Myriad Genetics
Commonwealth Biotechnologies
ZS Genetics
Pacific Biosciences
